Aktis Oncology Insiders Sold Shares Worth Over $2.8M

Czibere Akos, an officer serving as Chief Medical Officer, sold common stock on July 8, 2026 with reported weighted average prices of $27.1273, $27.9521 and $28.7078 per share for three separate disposals and a total reported sale amount of $1,388,701; following the reported transactions the reporting person no longer directly owns common stock of Aktis Oncology.

Ron-Bigger Shulamit, an officer serving as Chief Operating Officer, sold common stock in three transactions on July 8, 2026 with reported weighted average prices of $27.1317, $27.9379 and $28.7476 per share and a total reported sale amount of $1,387,557; following the reported transactions the reporting person no longer directly owns any common stock of Aktis Oncology.

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.